STAT3 and metabolic disease: A previous study demonstrated that upregulated MIR20B levels in obesity-induced metabolic disorders such as T2DM were considered to prevent several targets, such as STAT3, CD36, and PTEN, which are involved in glucose and lipid homeostasis.